Cholesterol (Cho) is a sterol that plays an essential role in the maintenance of biologic cell membranes, and various lipoproteins are its carriers through blood circulation [1] . Some FDA-approved anticancer drugs (i.e., Lipoplatin and Myocet) are conjugated to Cho moieties to improve their pharmacokinetic properties, cellular uptake and target specificity [2] . Recently natural and synthetic sterol compounds have shown a broad spectrum of pharmacological activities [3, 4] . Herein, we investigated the anticancer activity of various natural Cho analogs, ie. asiatic acid (AsA), betulinic acid (BeA), oleanolic acid (OleA), ursolic Acid (UrA), lupeol (Lupe) and b-sitosterol (b-Sito) against non-small cell lung adenocarcinoma (A549). We performed theoretical calculations of the biophysicochemical properties, and viability assays in a range of 5e100 mM in A549 cells of these Cho analogs.
Data
In this report, we present data on the cytotoxicity of Cho analogs: UrA, BeA, OleA, AsA, Lupe and b-Sito (structures in Table 1 ). Our Cho analogs are commercial plant-derived triterpenoids with Cho fundamental structure. Some of them (e.g., BeA, OleA and UrA) have shown anti-tumorigenic and antibacterial properties [3e6]. In the Table 1 we theoretically determined some of the physicochemical properties of the six Cho analogs compared to Cho, following some of the most important factors to overcome physiological barriers. The six analogs show bioavailability potential due to the high lipophilicity (LogP) in the same way as the Cho but with more ionizable groups (LogD). It is suggested that high lipophilic drugs will accumulate to a high concentration within the cellular membrane changing its fluidity and promoting cell death [1, 2, 7] . The cytotoxic effects of these Cho analogs were determined at different concentrations (5, 10, 25, 50, 75 and 100 mM) in the A549 cells after 24 h treatment. Viability of cells was measured by the colorimetric absorbance at 492 nm of the formazan dye produced after the addition of the MTS/PMS reagent. The intensity of the produced dye is correlated to the reduction of the MTS molecule, assisted by electron coupler PMS, by the NADH-dependent cellular oxidoreductase enzymes to generate a colored formazan product. The raw data and normalized values (after subtracting the background) are shown in the Table 2 . Graphics of the normalized data and IC 50 values determinations of the compounds are shown in the Fig. 1 . UrA, BeA, OleA, AsA and Lupe showed cytotoxic patterns in the micromolar range tested in this study. However, b-Sito did not show any significant cytotoxicity even at the highest concentration of 100mM. 10 mM stocks solutions of the six cholesterol (Cho) analogs, of cisplatin (positive control) and of Cho (negative control) were prepared in DMF solvent the same day of the cellular treatment. The compounds were incubated at different concentrations (5, 10, 25, 50, 75 and 100 mM) in A549 cells at 37 C and 5% CO 2 for 24h.
Experimental features
Cytotoxicity was determined by adding MTS/PMS reagent and measuring the colorimetric intensity after 24 h treatment with Cho analogs and controls. Graphics and IC 50 values determination were performed using GraphPad Prism 8 software.
Data source location
Caguas, Puerto Rico, USA
Data accessibility
All data are presented in this article. 
Value of the data
The data show the bioactivity of plant-derived Cho analogs in A549 cancer cells. The data are useful for synthetic chemists working on the development of anticancer drugs because they can create connections and comparisons between the potential drug and the proposed Cho-like structure analogs based on the calculated physicochemical properties.
The data indicate that five of the Cho analogs (UrA, BeA, OleA, AsA, and Lupe) showed cytotoxic effect at the micromolar range tested. However BeA showed the more potent cytotoxic pattern with the lowest IC50. On the contrary, besito did not show any significant cytotoxicity. In the methodology, a protocol is provided to easily screen different compounds for their cytotoxic patterns by MTS viability assay using CellTiter 96® AQueous MTS Reagent Powder and Phenazine methosulfate (PMS). A protocol to create graphics, analyze data and determine IC 50 values using GraphPad Prism 8 software. 
Materials
Aqueous solutions were prepared with sterile (autoclave conditions: 121 C and 18 PSI) high quality nanopure water (18.2 MU cm resistivity, Thermoscientific ® Easypure water purifier). The non-small lung human adenocarcinoma A549 cell line (ATCC ® CCL-185™) was purchased from American Type Culture Collection (ATCC; Manassas, VA). Dulbecco's modified eagle medium (DMEM), phosphate buffer saline (PBS), fetal bovine serum (FBS), phenazine methosulfate (PMS), penicillin/streptomycin antibiotic solution and Cho analogs (UrA, BeA, OleA, AsA, Lupe and b-sito) and Cho were ordered from Millipore Sigma (St. Louis, MO). CellTiter 96® AQueous MTS Reagent Powder was ordered from Promega. All other chemicals were of analytical grade and from various commercial suppliers and used without further purification.
Cell culture
A549 cells were maintained in accordance with the ATCC protocol. Briefly, cells were cultured in 75 cm 2 flasks with DMEM supplemented with 10% heat inactivated FBS and 1% antibiotic solution in a humidified incubator at 5% CO 2 and 37 C. All experiments were conducted before cells reached 30 passages. In each passage, cells were washed twice with PBS, trypsinized, and suspended in supplemented medium.
Viability assay
The cell viability of the A549 line, after being treated with the Cho analogs, was determined using the CellTiter 96 ® Aqueous MTS Reagent Powder (Promega). A549 cells were seeded in a 96-well plate at a density of 5 Â 10 3 cell/well and then incubated for 24 hours at 37 C and 5% CO 2 . Stocks of the Cho analogs: AsA, BeA, UrA, OleA, Lupe and b-Sito, were prepared at 10 mM in 1 mL of DMF. Dilutions of the Cho analogs were prepared in PBS to treat the cells at a range of 5, 10, 25, 50, 75 and 100 mM maintaining 1% of DMF in each well completing to a total volume of 200 mL. In non-treated cells, we added PBS and 1% DMF as a negative control and for background control, PBS and 1% DMF in wells without cells, to complete to the same total volume of 200 mL. Afterwards, the treated plate was incubated with the different compounds for 24 h. Following the incubation period and previous to the addition of the MTS/PMS solution, the plate was measured to obtain the background absorbances at 492 nm using a microplate reader spectrophotometer (Thermoscientific Multiskan FC). Then, 20 mL of MTS/PMS sterile solution [2 mg/mL MTS/0.21 mg/mL PMS] were added to each well followed by 1 hour of incubation in the dark at 37 C. Then, the absorbance at 492 nm was measured. Background absorbances were 
Relative cell viability ð%Þ ¼ Abs treated cells Abs nontreated cells x 100
Cho analogs-treated cells at their respective IC 50 were visualized under the microscope to confirm the results of the MTS/PMS assay. 
Statistical analysis
Viability results are reported as average ± SD of at least three independent experiments. IC 50 values and graphics were done using GraphPad Prism 8 software using the inhibitor vs normalize response method. 
